Cannabis-using schizophrenia patients paradoxically show better cognitive performance than non-using patients, possibly representing a distinct subgroup with less neurodevelopmental pathology.
Psychiatrists, neuropsychologists, and schizophrenia researchers.
Paradoxical findingcannabis-using schizophrenia patients show better cognition than non-users, possibly representing a distinct phenotype
What the researchers found
While cannabis harms cognition in healthy people and worsens psychotic symptoms, schizophrenia patients who use cannabis have better cognitive performance than non-users, a paradox explained by three competing hypotheses.
Why it matters
Understanding this paradox could reveal new therapeutic approaches. If cannabis-using patients represent a distinct phenotype, this has implications for personalized treatment.
The numbers in context
Cognitive advantages seen in lifetime but not current cannabis users with schizophrenia. Earlier age of use (<17) associated with better cognition but earlier illness onset. Multiple factors modify outcomes.
How the study worked
Narrative review synthesizing human clinical studies, epidemiological data, and animal model research on cannabis-cognition interactions in schizophrenia.
Who was studied
Review covers schizophrenia patients, healthy cannabis users, and animal models.
What this study cannot tell us
Narrative review without systematic methodology. The paradox may reflect selection bias rather than causal effects. Animal models have limited translational relevance.
How to read the evidence
Comprehensive narrative review of a complex literature; highlights unresolved questions.
When this study was published
Recent review integrating human and animal research.
The bigger picture
This review highlights the enormous complexity of cannabis-schizophrenia interactions and suggests that simple narratives about cannabis being uniformly harmful or helpful are inadequate.
Replication
Review of existing paradox; prospective studies needed to distinguish hypotheses.
Funding
Not specified in abstract
Conflicts of interest
Not specified in abstract
Questions still open
- Is the cognitive advantage in cannabis-using patients a selection effect or a cannabis effect?
- Could CBD explain some of the cognitive benefits observed in cannabis users with schizophrenia?
Read the original research
The Relationship Between Cannabis, Cognition, and Schizophrenia: It's Complicated.
Current topics in behavioral neurosciences, 63, 437-461
Citation
Kayir, Hakan; Ruffolo, Jessica; McCunn, Patrick; Khokhar, Jibran Y. (2023). The Relationship Between Cannabis, Cognition, and Schizophrenia: It's Complicated.. Current topics in behavioral neurosciences, 63, 437-461. https://doi.org/10.1007/7854_2022_396